Navigation Links
Qualyst Transporter Solutions, LLC Announces New Alliance with GenoMembrane

RESEARCH TRIANGLE PARK, N.C., Jan. 21, 2013 /PRNewswire-iReach/ -- Qualyst Transporter Solutions, LLC, has recently announced an alliance with GenoMembrane, Kanagawa, Japan to make available its B-CLEAR® Technology to customers in Japan.  The initial offering will focus on supplying B-CLEAR® kits of rat and human hepatocytes, both plated with Transporter Certified™ hepatocytes.  In addition, contract services projects can be facilitated through GenoMembrane.  The alliance will facilitate access to B-CLEAR® technology in Japan, which can be used to predict the biliary excretion of drugs, evaluate clinically relevant drug interactions, determine the cholestatic potential of drugs, and estimate their intracellular concentration.

"B-CLEAR® human kits for Japan use cryopreserved human hepatocytes that have been certified for transporter function (uptake and efflux), providing the customer with clinically relevant data, and a high level of reproducibility from experiment to experiment." said Dr. Christopher Black , CEO for Qualyst Transporter Solutions.

Qualyst Transporter Solutions only uses Transporter Certified™ hepatocytes in its kits and services to examine the potential for in vivo relevant transporter-based drug interactions.  The key to obtaining in vivo-relevant answers is to use a fully integrated, functioning cell system that has been certified for transporter function.  "We certify our hepatocytes to ensure a fully functioning complement of uptake and efflux transporters, which guarantees that the results are in vivo-relevant," said Dr. Kenneth Brouwer , CSO for Qualyst Transporter Solutions.

"We are excited that we can now offer B-CLEAR® kits with both rat and human hepatocytes to our Japanese customers, as well as an opportunity to offer other relevant research services conducted by Qualyst Transporter Solutions," said Mr. Satoshi Senda , CEO for GenoMembrane.

About Qualyst Transporter Solutions, LLC
In addition to it's patented B-CLEAR® technology, Qualyst Transporter Solutions commercializes novel and proprietary drug transport and hepatobiliary disposition products for drug discovery and development.  Qualyst Transporter Solutions products provide answers to transporter questions that arise in drug discovery and development.  For additional information, please refer to the company's web site at or call (919) 313-6500.  B-CLEAR® technology is covered by US (# 6780580), EU (#1163517) and JP (#4451570) patents issued and pending.

About GenoMembrane
GenoMembrane Co., Ltd. provides transporter-related products and services that are critical in the development and design of novel drugs for clinical applications.  GenoMembrane also provides research tools and collaborates for the pharmacological evaluation of drug candidates to minimize costs, help improve the success rate of candidate drugs, and speed up new drug development. For additional information, please refer to the company's web site at

Media Contact

US:  Qualyst Transporter Solutions, Christopher Black , Ph.D. Chief Executive Officer, (919) 313-6511,

Japan: GenoMembrane, Satoshi Senda , Chief Executive Officer, +81(45)508-2326,

Media Contact: Christopher Black Qualyst Transporter Solutions, LLC, 9192978681,

News distributed by PR Newswire iReach:

SOURCE Qualyst Transporter Solutions, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Absorption Systems announces novel test platform for interactions with the BCRP transporter
2. Cardinal Health Specialty Solutions, Health Alliance Plan Work With Michigan Oncologists to Improve Quality, Curb Costs of Cancer Care
3. Catalent Pharma Solutions, Inc. Announces Increase In Tender Cap For Its Cash Tender Offer For Its 9-1/2%/10-1/4% Senior PIK-Election Notes Due 2015
4. Catalent Pharma Solutions, Inc. Announces Cash Tender Offer for up to $250 Million of Its 9-1/2%/10-1/4% Senior PIK-Election Notes due 2015
5. Pristine Solutions, Inc. Completes Acquisition of Eaton Scientific Systems, Ltd. - Enters Multi-Billion Dollar Womens Health and Drug Sector
6. Frost & Sullivan Recognizes Terso Solutions, Inc. with 2012 Best Practices Award
7. Cardiosolutions, Inc. Gathers Major Investment from Sorin Group
8. Cardiosolutions, Inc. Receives FDA 510(k) Clearance for Dexterity™ Steerable Introducer
9. Block Engineering Announces Collaborative Agreement with Pfizer for Next Generation Cleaning Verification Technology
10. Robbins Arroyo LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Hemispherx Biopharma, Inc.
11. Express Scripts Holding Company Announces Fourth Quarter 2012 Earnings Conference Call
Post Your Comments:
(Date:11/25/2015)... 25, 2015 AAIPharma Services Corp./Cambridge Major ... at least $15.8  Million to expand its laboratories ... . The expansion will provide additional office ... growing demands of the pharmaceutical and biotechnology markets. ... will provide up to 40,000 square feet of ...
(Date:11/25/2015)... 25, 2015  Henry Schein, Inc., the world,s largest ... dental, medical and animal health practitioners, will unveil at ... Henry Schein ConnectDental® Pavilion , which brings together for ... solutions designed to help any practice or laboratory enter ... for a schedule of experts appearing at the Pavilion. ...
(Date:11/25/2015)... , Nov. 25, 2015  Trovagene, Inc. (NASDAQ: ... announced that Chief Executive Officer Antonius Schuh, Ph.D., is ... th Annual Piper Jaffray Healthcare Conference. ... New York Palace Hotel in New York ... p.m. EST. Mr. Schuh will be available for one-on-one ...
Breaking Medicine Technology:
(Date:11/28/2015)... ... November 28, 2015 , ... Pixel Film Studios is ... panels to choose from, the possibilities are endless. Users have full control over angle ... ProPanel: Pulse masking effects, users are sure to get heads to turn. , ProPanel: ...
(Date:11/27/2015)... ... , ... The rapid speed at which Americans are aging ... is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming more prevalent. ... part of this equation: 80 percent of medical care occurs in the home, ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component ... Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of ... distributed nationally, through a vast social media strategy and across a network of ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, "Voices in ... that delves into an array of issues that are presently affecting Americans. Dedicated to ... dialogue, this show is changing the subjects consumers focus on, one episode at a ...
(Date:11/27/2015)... ... November 27, 2015 , ... Dr. Thomas Dunlap ... Inc. and Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph Health ... both STEMI and Sepsis conditions present in similar ways and require time-critical intervention to ...
Breaking Medicine News(10 mins):